Cargando…

Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza

BACKGROUND: Newcastle disease (ND) and avian influenza subtype H9N2 (H9N2 AI) are two of the most important diseases of poultry, causing severe economic losses in the global poultry industry. Vaccination is an effective way to prevent and control the spread of ND virus (NDV) and H9N2 AI virus (AIV),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Yang, Huiming, Xu, Hongjun, Ma, Zengbin, Zhang, Guozhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356287/ https://www.ncbi.nlm.nih.gov/pubmed/28302119 http://dx.doi.org/10.1186/s12985-017-0723-7

Ejemplares similares

Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains
por: Azab, Ahmed A., et al.
Publicado: (2023)

Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks
por: Teng, Qiaoyang, et al.
Publicado: (2015)

Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants
por: Cahyani, Jossie Intan, et al.
Publicado: (2020)

Interaction between avian influenza subtype H9N2 and Newcastle disease virus vaccine strain (LaSota) in chickens
por: Ellakany, Hany F., et al.
Publicado: (2018)

Efficacy of Single Dose of a Bivalent Vaccine Containing Inactivated Newcastle Disease Virus and Reassortant Highly Pathogenic Avian Influenza H5N1 Virus against Lethal HPAI and NDV Infection in Chickens
por: Lee, Dong-Hun, et al.
Publicado: (2013)

Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus
por: Ali, Zeinab Mohamed, et al.
Publicado: (2017)

Seroepidemiology of avian influenza H5N1, H9N2 & Newcastle disease viruses during 1954 to 1981 in India
por: Pawar, Shailesh D., et al.
Publicado: (2016)

Assessing the efficacy of a recombinant H9N2 avian influenza virus–inactivated vaccine
por: Song, Cai Liang, et al.
Publicado: (2020)

Conventional inactivated bivalent H5/H7 vaccine prevents viral localization in muscles of turkeys infected experimentally with low pathogenic avian influenza and highly pathogenic avian influenza H7N1 isolates
por: Toffan, Anna, et al.
Publicado: (2008)

Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus
por: Zhang, Xiaorong, et al.
Publicado: (2021)

Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract
por: Shao, Guanming, et al.
Publicado: (2022)

Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine
por: Choi, Jun-Gu, et al.
Publicado: (2010)

An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea
por: Choi, Jun Gu, et al.
Publicado: (2008)

Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses
por: Hu, Jiao, et al.
Publicado: (2021)

Development of an Inactivated Avian Influenza Virus Vaccine against Circulating H9N2 in Chickens and Ducks
por: Liu, Yuzhuo, et al.
Publicado: (2023)

An intelligent device for diagnosing avian diseases: Newcastle, infectious bronchitis, avian influenza
por: Banakar, Ahmad, et al.
Publicado: (2016)

Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles
por: Khalili, Iraj, et al.
Publicado: (2015)

Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine
por: Astill, Jake, et al.
Publicado: (2018)

Genesis of avian influenza H9N2 in Bangladesh
por: Shanmuganatham, Karthik, et al.
Publicado: (2014)

Human Infected H7N9 Avian Influenza
por: Shi, Yuxin, et al.
Publicado: (2016)

Prevalence and diversity of H9N2 avian influenza in chickens of Northern Vietnam, 2014
por: Thuy, Duong Mai, et al.
Publicado: (2016)

Adjuvant Activity of Sargassum pallidum Polysaccharides against Combined Newcastle Disease, Infectious Bronchitis and Avian Influenza Inactivated Vaccines
por: Li, Li-Jie, et al.
Publicado: (2012)

Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes
por: Bortolami, Alessio, et al.
Publicado: (2022)

Chlorine Inactivation of Highly Pathogenic Avian Influenza Virus (H5N1)
por: Rice, Eugene W., et al.
Publicado: (2007)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Genome Sequences of an H9N2 Avian Influenza Virus Strain Found in Pakistan in 2017
por: Lee, Dong-Hun, et al.
Publicado: (2019)

Internal Gene Cassette From a Human-Origin H7N9 Influenza Virus Promotes the Pathogenicity of H9N2 Avian Influenza Virus in Mice
por: Zhang, Miaomiao, et al.
Publicado: (2020)

Inactivation of the novel avian influenza A (H7N9) virus under physical conditions or chemical agents treatment
por: Zou, Shumei, et al.
Publicado: (2013)

Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses
por: Naggar, Heba M. El, et al.
Publicado: (2017)

PA-X is an avian virulence factor in H9N2 avian influenza virus
por: Clements, Anabel L., et al.
Publicado: (2021)

Phylogeography of Avian influenza A H9N2 in China
por: Jin, Yuan, et al.
Publicado: (2014)

The Multifaceted Zoonotic Risk of H9N2 Avian Influenza
por: Pusch, Elizabeth A., et al.
Publicado: (2018)

Inactivation of Avian Influenza Virus, Newcastle Disease Virus and Goose Parvovirus Using Solution of Nano-Sized Scallop Shell Powder
por: THAMMAKARN, Chanathip, et al.
Publicado: (2014)

Assessment of the safety and efficacy of low pathogenic avian influenza (H9N2) virus in inactivated oil emulsion vaccine in laying hens
por: Shin, Jeong-Hwa, et al.
Publicado: (2016)

Comparative Pathogenicity and Transmissibility of the H7N9 Highly Pathogenic Avian Influenza Virus and the H7N9 Low Pathogenic Avian Influenza Virus in Chickens
por: Yu, Hao, et al.
Publicado: (2019)

Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9
por: Li, Jinping, et al.
Publicado: (2018)

Analysis of the full-length genome of a novel strain of the H7N9 avian influenza virus
por: OU, XINHUA, et al.
Publicado: (2014)

Characterization of an Avian Influenza Virus H9N2 Strain Isolated from Dove in Southern China
por: Li, Dan, et al.
Publicado: (2018)

Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
por: Sun, Zhihao, et al.
Publicado: (2021)

Newcastle Disease Virus Vectored Bivalent Vaccine against Virulent Infectious Bursal Disease and Newcastle Disease of Chickens
por: Dey, Sohini, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eomhanf4cfbi78pavu65hdk01t